Ovarian cancer

Open Access
Metabolism-driven Immune Escape Defines Therapeutic Vulnerability in Type I and Type II Ovarian Cancer
KOHEI MIYATA and FUSANORI YOTSUMOTO

Anticancer Research May 2026, 46 (5) 2851-2861; DOI: https://doi.org/10.21873/anticanres.18164
Open Access
Inflammatory Cytokine Genotypic Markers and Ovarian Cancer Risk
WEN-SHIN CHANG, CHIA-WEN TSAI, JAW-CHYUN CHEN, YUN-CHI WANG and DA-TIAN BAU

Anticancer Research May 2026, 46 (5) 2863-2876; DOI: https://doi.org/10.21873/anticanres.18165
You have access
Risk Factors for Niraparib-induced Severe Anemia in Japanese Patients With Ovarian Cancer: A Multicenter Study
YUKI OZAWA, HIROMU TANIGAWA, TATSUHIRO FUJIMIYA, YOSHIKI ABE, JOH HIROHARA, MARII SUEHIRO, YUKI TANAKA, NAOKI SHIBATA, TAKASHI YOKOKAWA, JUNICHI KUSANO, TORU ARASE and TAKUMA KOINUMA

Anticancer Research May 2026, 46 (5) 2887-2897; DOI: https://doi.org/10.21873/anticanres.18167
You have access
Ascites: A Potential Diagnostic Surrogate for Genetic Profiling in Ovarian Cancer
ESTRID V. HØGDALL, LAU K. VESTERGAARD, DOUGLAS N.P. OLIVEIRA, TIM S. POULSEN and CLAUS K. HØGDALL

Anticancer Research May 2026, 46 (5) 2899-2913; DOI: https://doi.org/10.21873/anticanres.18168
Open Access
The Impact of Exercise and Diet on Ovarian Cancer Mortality
JOHN P. MICHA, RANDY BOHART and BRAM H. GOLDSTEIN

Anticancer Research April 2026, 46 (4) 1763-1768; DOI: https://doi.org/10.21873/anticanres.18072
Open Access
Primary Debulking Surgery Versus Interval Debulking Surgery in the Management of Advanced-Stage Ovarian Cancer
JOHN P. MICHA, RANDY D. BOHART, JOSHUA P. GORMAN and BRAM H. GOLDSTEIN

Anticancer Research March 2026, 46 (3) 1175-1182; DOI: https://doi.org/10.21873/anticanres.18021
You have access
Postmenopausal Stage IV Ovarian Yolk Sac Tumor With Neuroendocrine Features: Report of a Rare Case
STEFANO FUCINA, LUCIA LERDA, MICHELE BARTOLETTI, ALESSANDRA PERIN, VINCENZO CANZONIERI and ANTONINO DITTO

Anticancer Research February 2026, 46 (2) 1167-1172; DOI: https://doi.org/10.21873/anticanres.18019
Open Access
Paucimannosylation Is a Prognostic Marker in High-grade Serous Ovarian Cancer
EVA EGGER, SARAH FÖRSTER, LINA ADLOFF, MILKA MARINOVA, LUCIA A. OTTEN, CAROLIN SCHRÖDER, DOMINIQUE KÖNSGEN, ALEXANDER MUSTEA, THORE THIESLER and MICHAEL MUDERS

Anticancer Research January 2026, 46 (1) 85-94; DOI: https://doi.org/10.21873/anticanres.17925
You have access
Prognostic Value of Tertiary Lymphoid Structures in Epithelial Ovarian Carcinoma
TAKEHIRO NAKAO, KENICHI HARANO, MASASHI WAKABAYASHI, TETSURO TAKI, REIKO WATANABE, HIROSHI TANABE and TORU MUKOHARA

Anticancer Research December 2025, 45 (12) 5543-5555; DOI: https://doi.org/10.21873/anticanres.17889
You have access
Efficacy of Platinum-based Chemotherapy for Platinum-sensitive Recurrent Ovarian Cancer During PARP Inhibitor Treatment: A Multicenter Retrospective Study
ERIKO TAKATORI, TADAHIRO SHOJI, AMI JO, MIKU MUSASHI, SHUNSUKE TATSUKI, NANAKO JONAI, YOHEI CHIBA, SHO SATO, YOSHITAKA KAIDO, TAKAYUKI NAGASAWA, MASAHIRO KAGABU, FUMIAKI TAKAHASHI, TAKESHI AIDA and TSUKASA BABA

Anticancer Research December 2025, 45 (12) 5773-5783; DOI: https://doi.org/10.21873/anticanres.17910

Main menu

User menu

Search

Ovarian cancer

Pages